Marijuana users more likely to need emergency care and hospitalization, study finds
“Our research demonstrates that cannabis use in the general population is associated with heightened risk of clinically serious negative outcomes, specifically, needing to present to the ED [emergency department] or be admitted to hospital,”
- Cannabis users were 22 percent more likely than those who don’t use to land in the emergency room or become hospitalized for any reason, suggesting use of the drug may be associated with negative health outcomes.
- Bodily injury was the top reason for emergency department visits and hospitalizations among marijuana users, while respiratory issues came in second.
- While recreational marijuana is still illegal in the U.S. under federal law, at least 19 states have passed legislation to allow sales of the drug.
(Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study | BMJ Open Respiratory Research)
For complete article Marijuana users more likely to need emergency care and hospitalization, study finds
Careful with OTC CBD – Very Careful
Cannabidiol (CBD) products made from hemp have gotten more popular in recent years. But how much can you trust what the label says, compared to what really is in CBD patches, creams, and lotions?
A team of investigators decided to find out. They bought 105 hemp-derived CBD topicals – products designed to be applied to the skin – from physical stores and online sites.
Of the 89 labels that list the amount of CBD, for example, 24% matched what was inside; 58% of the products had more CBD; and the remaining 18% contained less.
Also, more than a third – 35% – of the topicals tested contained delta-9-tetrahydrocannabinol (THC), including some that claimed to be THC-free.
Can Be Deceiving
CBD topicals are over-the-counter (OTC) products, so the FDA does not regulate them the same way as prescription medications. But at the same time, the agency does not allow OTC products to make claims about health benefits.
"The health claims made on the products, which are often very pricey, may not be supported by clinical research…This study really highlights that current regulatory oversight of cannabinoid products is not sufficient," says Spindle, who is also an assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine and Cannabis Science Laboratory in Baltimore.
For complete article Careful with CBD – Very Careful: Some CBD Creams, Patches Don't Match Labels: Study
For JAMA Research Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores JAMA Network Open
|
|
High-strength cannabis linked to addiction and mental health problems
by University of Bath
Researchers from the Addiction and Mental Health Group at the University of Bath (UK) have systematically analyzed the relationship between the types of cannabis people use and their addiction and mental health problems. Their work draws on 20 studies involving almost 120,000 people.
The new study, published in The Lancet Psychiatry, suggests that people who use high-potency cannabis are more likely to experience addiction than those using low-potency products. It also suggests that people using high-potency cannabis are more likely to experience a psychotic disorder, such as schizophrenia.
These findings may help to explain why more people have received treatment for cannabis problems over recent years. Data from the European Monitoring Centre for Drugs and Drug Addiction show a 76% increase in people entering treatment for cannabis addiction in the past decade.
"These results are important in the context of harm reduction, which aims to minimize the negative consequences associated with drug use. While the safest level of use for cannabis is of course 'no use,' it is important to acknowledge that a significant number of people across the world use cannabis regularly, and to ensure they can make informed decisions that could reduce any possible harms associated with it."
For complete article go to High-strength cannabis linked to addiction and mental health problems
Further Reading
How Men's Cannabis Use Could Affect Their Kids' Health
Research on pot and sperm quality, gene expression, and child development.
July 28, 2022
KEY POINTS
- Paternal consumption of marijuana prior to conception has been found in rodent studies to alter offspring brain development.
- Children whose fathers consumed marijuana during their partner's pregnancy may be at higher risk of psychotic symptoms.
- Pot consumption can trigger epigenetic changes in gene expression, which fathers can pass along to their children.
- Not all human studies of pot's effects on male fertility are consistent. A dose-dependent relationship between pot and male fertility may exist.
Accumulating evidence suggests that a man’s lifetime cannabis consumption can influence his fertility as well as the health and development of his future children. While occasional use may not have terrible consequences, prospective fathers (and their partners) should be mindful of how marijuana use, especially in the months leading up to conception, can affect sperm—and the expression of genes those sperm pass on to offspring.
For complete article go to How Men's Cannabis Use Could Affect Their Kids' Health
|
|
Effects of cannabis on congenital limb anomalies in 14 European nations: A geospatiotemporal and causal inferential study (Europe is not exempt from cannabis caused congenital cannabis defects)
Data indicate that metrics of cannabis exposure are closely linked with CLAR and satisfy epidemiological criteria for causality. Along with Hawaii and the USA, Europe now forms the third international population in which this causal link has been demonstrated. Cannabis as a predictor of limb anomalies was more potent than tobacco or alcohol. Cannabinoid access should be restricted to protect public health and the community genome/epigenome transgenerationally.
For complete research go to Effects of cannabis on congenital limb anomalies in 14 European nations: A geospatiotemporal and causal inferential study
|
|
|
Like us on 'YouTube' 'Twitter' and 'Facebook' by clicking on the images below.
Also please consider a donation to our important work by clicking on the 'donation' image below
|
|
|
|
